Home›People›Gjalt Huisman
GH

Gjalt Huisman

CEO and director at Embold Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Jul 24, 2026·Suggest an edit

About Gjalt Huisman

Gjalt Huisman is CEO and director at Embold Therapeutics.

Experience

This experience comes from Gjalt Huisman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gjalt Huisman in the role, so the role may have started earlier or lasted longer.

Embold Therapeutics, Inc. Current
Chief Executive Officer (2023 – Present)
Director
2023 – Present · Redwood City, CA
Develops enzyme-based treatments for people with Parkinson’s disease.
Enzyme Tech Consulting Current
Consultant
2022 – Present
Codexis, Inc.
Senior Vice President, Strategic Development; General Manager, Biotherapeutics
2002 – 2022
Maxygen
Director of Research and Product Manager, Pharmaceuticals
1998 – 2002
Metabolix
Research Scientist and Group Leader Molecular Biology
1994 – 1998

Sources

  1. SECEmbold Therapeutics, Inc. Form D/A, filed Jul 24, 2026